Pages

Monday, December 21, 2015

USP Urges FDA To Rethink Biosimilar Naming Guidance Pharmacy Practice News-


USP Urges FDA To Rethink Biosimilar Naming Guidance

Pharmacy Practice News-11 hours ago
... a unique name is necessary,” said Gillian Woollett, MA, DPhil, the senior vice president at Avalere Health, in an interview with Specialty

No comments:

Post a Comment